Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Bioorg Chem ; 139: 106747, 2023 10.
Article in English | MEDLINE | ID: mdl-37531819

ABSTRACT

Ceramides impact a diverse array of biological functions and have been implicated in disease pathogenesis. The enzyme neutral ceramidase (nCDase) is a zinc-containing hydrolase and mediates the metabolism of ceramide to sphingosine (Sph), both in cells and in the intestinal lumen. nCDase inhibitors based on substrate mimetics, for example C6-urea ceramide, have limited potency, aqueous solubility, and micelle-free fraction. To identify non-ceramide mimetic nCDase inhibitors, hit compounds from an HTS campaign were evaluated in biochemical, cell based and in silico modeling approaches. A majority of small molecule nCDase inhibitors contained pharmacophores capable of zinc interaction but retained specificity for nCDase over zinc-containing acid and alkaline ceramidases, as well as matrix metalloprotease-3 and histone deacetylase-1. nCDase inhibitors were refined by SAR, were shown to be substrate competitive and were active in cellular assays. nCDase inhibitor compounds were modeled by in silico DOCK screening and by molecular simulation. Modeling data supports zinc interaction and a similar compound binding pose with ceramide. nCDase inhibitors were identified with notably improved activity and solubility in comparison with the reference lipid-mimetic C6-urea ceramide.


Subject(s)
Ceramides , Neutral Ceramidase , Catalytic Domain , Ceramides/chemistry , Neutral Ceramidase/antagonists & inhibitors , Sphingosine/chemistry
2.
J Biol Chem ; 289(27): 18893-903, 2014 Jul 04.
Article in English | MEDLINE | ID: mdl-24817118

ABSTRACT

Eukaryotic mitotic entry is controlled by Cdk1, which is activated by the Cdc25 phosphatase and inhibited by Wee1 tyrosine kinase, a target of the ubiquitin proteasome pathway. Here we use a reporter of Wee1 degradation, K328M-Wee1-luciferase, to screen a kinase-directed chemical library. Hit profiling identified CK1δ-dependent Wee1 degradation. Small-molecule CK1δ inhibitors specifically disrupted Wee1 destruction and arrested HeLa cell proliferation. Pharmacological inhibition, siRNA knockdown, or conditional deletion of CK1δ also reduced Wee1 turnover. Thus, these studies define a previously unappreciated role for CK1δ in controlling the cell cycle.


Subject(s)
Casein Kinase Idelta/metabolism , Cell Cycle Proteins/metabolism , Nuclear Proteins/metabolism , Protein-Tyrosine Kinases/metabolism , Proteolysis , Amino Acid Sequence , Animals , Casein Kinase Idelta/antagonists & inhibitors , Cell Cycle/drug effects , Cell Cycle Proteins/chemistry , Drug Evaluation, Preclinical , HeLa Cells , Humans , Mice , Molecular Sequence Data , Nuclear Proteins/chemistry , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Protein Stability/drug effects , Protein-Tyrosine Kinases/chemistry , Proteolysis/drug effects , Small Molecule Libraries/pharmacology
3.
J Org Chem ; 79(17): 8469-76, 2014 Sep 05.
Article in English | MEDLINE | ID: mdl-25119296

ABSTRACT

A modular titanium-promoted coupling of unsymmetrical internal alkynes with Weinreb amides is described. The coupling reaction takes place at room temperature and affords E-trisubstituted enones in moderate to good yields with high levels of regioselectivity. The system shows moderate chemoselectivity.


Subject(s)
Alkynes/chemistry , Amides/chemical synthesis , Titanium/chemistry , Amides/chemistry , Catalysis , Molecular Structure , Stereoisomerism
4.
Bioorg Med Chem Lett ; 23(15): 4374-80, 2013 Aug 01.
Article in English | MEDLINE | ID: mdl-23787102

ABSTRACT

The development of a series of potent and highly selective casein kinase 1δ/ε (CK1δ/ε) inhibitors is described. Starting from a purine scaffold inhibitor (SR-653234) identified by high throughput screening, we developed a series of potent and highly kinase selective inhibitors, including SR-2890 and SR-3029, which have IC50 ≤ 50 nM versus CK1δ. The two lead compounds have ≤100 nM EC50 values in MTT assays against the human A375 melanoma cell line and have physical, in vitro and in vivo PK properties suitable for use in proof of principle animal xenograft studies against human cancer cell lines.


Subject(s)
Antineoplastic Agents/chemistry , Casein Kinase 1 epsilon/antagonists & inhibitors , Casein Kinase Idelta/antagonists & inhibitors , Animals , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Binding Sites , Casein Kinase 1 epsilon/metabolism , Casein Kinase Idelta/metabolism , Catalytic Domain , Cell Line, Tumor , Cell Survival , Half-Life , Humans , Mice , Microsomes, Liver/metabolism , Molecular Docking Simulation , Neoplasms/drug therapy , Purines/chemistry , Purines/pharmacokinetics , Purines/therapeutic use , Rats , Structure-Activity Relationship , Transplantation, Heterologous
5.
SLAS Discov ; 27(1): 8-19, 2022 01.
Article in English | MEDLINE | ID: mdl-35058179

ABSTRACT

The severe acute respiratory syndrome coronavirus 2 responsible for COVID-19 remains a persistent threat to mankind, especially for the immunocompromised and elderly for which the vaccine may have limited effectiveness. Entry of SARS-CoV-2 requires a high affinity interaction of the viral spike protein with the cellular receptor angiotensin-converting enzyme 2. Novel mutations on the spike protein correlate with the high transmissibility of new variants of SARS-CoV-2, highlighting the need for small molecule inhibitors of virus entry into target cells. We report the identification of such inhibitors through a robust high-throughput screen testing 15,000 small molecules from unique libraries. Several leads were validated in a suite of mechanistic assays, including whole cell SARS-CoV-2 infectivity assays. The main lead compound, calpeptin, was further characterized using SARS-CoV-1 and the novel SARS-CoV-2 variant entry assays, SARS-CoV-2 protease assays and molecular docking. This study reveals calpeptin as a potent and specific inhibitor of SARS-CoV-2 and some variants.


Subject(s)
Antiviral Agents/pharmacology , COVID-19 Drug Treatment , Cysteine Proteinase Inhibitors/pharmacology , Dipeptides/pharmacology , Virus Attachment/drug effects , Virus Internalization/drug effects , Angiotensin-Converting Enzyme 2/metabolism , Animals , Cathepsin L/antagonists & inhibitors , Cell Line , Chlorocebus aethiops , Drug Evaluation, Preclinical , Drug Repositioning , HEK293 Cells , Humans , Molecular Docking Simulation , SARS-CoV-2/drug effects , SARS-CoV-2/growth & development , Serine Endopeptidases/metabolism , Spike Glycoprotein, Coronavirus/metabolism , Vero Cells
6.
Org Lett ; 18(19): 5090-5093, 2016 10 07.
Article in English | MEDLINE | ID: mdl-27678270

ABSTRACT

α,ß-Unsaturated amides are important building blocks and are key structural elements in a number of biologically active natural products. Despite their importance and prevalence, few methods exist to prepare conjugated amides directly and modularly. To address this gap, a titanium-promoted coupling of alkynes and isocyanates has been developed. The method is highly stereoselective, producing only the E isomer with good chemoselectivity and regioselectivity (>95/5), for unsymmetrical internal alkynes that contain a steric bias. The reactive titanacyclopentene intermediate formed from the coupling of the alkyne and isocyanate was additionally reacted with various electrophiles to access tetrasubstituted enamides.

7.
Org Lett ; 7(22): 5087-90, 2005 Oct 27.
Article in English | MEDLINE | ID: mdl-16235964

ABSTRACT

[reaction: see text] Room-temperature reduction of aromatic nitro groups to amines can be accomplished in high yield, with wide functional group tolerance and short reaction times (30 min) using a combination of palladium(II) acetate, aqueous potassium fluoride, and polymethylhydrosiloxane (PMHS). Replacing PMHS/KF with triethylsilane allows aliphatic nitro groups to be reduced to their hydroxylamines.


Subject(s)
Hydrocarbons, Aromatic/chemistry , Hydrocarbons/chemistry , Nitro Compounds/chemistry , Palladium/chemistry , Silanes/chemistry , Siloxanes/chemistry , Catalysis , Molecular Structure , Oxidation-Reduction
8.
Cell Rep ; 11(2): 249-60, 2015 Apr 14.
Article in English | MEDLINE | ID: mdl-25843713

ABSTRACT

Although casein kinase 1δ (CK1δ) is at the center of multiple signaling pathways, its role in the expansion of CNS progenitor cells is unknown. Using mouse cerebellar granule cell progenitors (GCPs) as a model for brain neurogenesis, we demonstrate that the loss of CK1δ or treatment of GCPs with a highly selective small molecule inhibits GCP expansion. In contrast, CK1δ overexpression increases GCP proliferation. Thus, CK1δ appears to regulate GCP neurogenesis. CK1δ is targeted for proteolysis via the anaphase-promoting complex/cyclosome (APC/C(Cdh1)) ubiquitin ligase, and conditional deletion of the APC/C(Cdh1) activator Cdh1 in cerebellar GCPs results in higher levels of CK1δ. APC/C(Cdh1) also downregulates CK1δ during cell-cycle exit. Therefore, we conclude that APC/C(Cdh1) controls CK1δ levels to balance proliferation and cell-cycle exit in the developing CNS. Similar studies in medulloblastoma cells showed that CK1δ holds promise as a therapeutic target.


Subject(s)
Anaphase-Promoting Complex-Cyclosome/biosynthesis , Casein Kinase Idelta/biosynthesis , Cdh1 Proteins/biosynthesis , Central Nervous System/growth & development , Neurogenesis/genetics , Anaphase-Promoting Complex-Cyclosome/genetics , Animals , Casein Kinase Idelta/genetics , Cdh1 Proteins/genetics , Cell Cycle/genetics , Cell Proliferation/genetics , Central Nervous System/metabolism , Cerebellum/growth & development , Cerebellum/metabolism , Gene Expression Regulation, Developmental , HeLa Cells , Humans , Mice , Neurons/metabolism , RNA Interference , Signal Transduction
9.
Org Lett ; 16(5): 1330-3, 2014 Mar 07.
Article in English | MEDLINE | ID: mdl-24552627

ABSTRACT

A selective iridium catalyzed hydrosilylation of alkenes in the presence of more reactive alkynes is described. By utilizing [IrCl(COD)]2 in the presence of excess COD, hydrosilylation of alkenes and alkynes with ethynylsilanes is achieved with good chemo- and regioselectivity. This approach goes against the traditional reactivity trends of platinum and rhodium catalysts and allows access to highly substituted silicon alkyne tethers.


Subject(s)
Alkenes/chemistry , Alkynes/chemistry , Alkynes/chemical synthesis , Iridium/chemistry , Silanes/chemistry , Silanes/chemical synthesis , Catalysis , Combinatorial Chemistry Techniques , Molecular Structure , Platinum/chemistry , Rhodium/chemistry , Stereoisomerism
10.
Org Lett ; 13(4): 584-7, 2011 Feb 18.
Article in English | MEDLINE | ID: mdl-21247081

ABSTRACT

Catalytic Pd(OAc)(2) and polymethylhydrosiloxane (PMHS), in conjunction with aqueous KF, and a catalytic amount of an aromatic chloride, effects the chemo-, regio-, and stereoselective deoxygenation of benzylic oxygenated substrates at room temperature in THF. Preliminary mechanistic experiments suggest the process to involve palladium-nanoparticle-catalyzed hydrosilylation followed by C-O reduction. The chloroarene additive appears to facilitate the hydrogenolysis process through the slow controlled release of HCl.


Subject(s)
Carbon/chemistry , Nanoparticles/chemistry , Oxygen/chemistry , Palladium/chemistry , Siloxanes/chemistry , Catalysis , Combinatorial Chemistry Techniques , Hydrocarbons, Chlorinated/chemistry , Hydrochloric Acid/chemistry , Molecular Structure , Oxidation-Reduction , Stereoisomerism
11.
J Org Chem ; 73(7): 2912-5, 2008 Apr 04.
Article in English | MEDLINE | ID: mdl-18331056

ABSTRACT

A rapid and high-yielding silylation of terminal alkynes employing TMSOTf and catalytic quantities of Zn(OTf)2 has been developed. The reaction works well for a variety of substrates including reactive esters. Fifteen examples with yields of >90% are reported.


Subject(s)
Alkynes/chemistry , Organometallic Compounds/chemistry , Organosilicon Compounds/chemical synthesis , Zinc/chemistry , Catalysis , Molecular Structure , Organosilicon Compounds/chemistry , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL